Octagon Capital Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Octagon Capital Advisors’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,400,000	Closed	-$1.55M	–	46
2022 Q4	$1.55M	Hold	1,400,000	–	–	0.24%	29
2022 Q3	$3.28M	Buy	+1,400,000	New	+$4.96M	0.57%	25

Other funds holding JNCE

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Tudor Investment Corp

Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return

Ardent Capital Management Cincinnati, Ohio $234M AUM 15.81% 1-Year Est. Return